Mostrando 4 resultados de: 4
Filtros aplicados
Subtipo de publicación
Article(4)
Publisher
Breast Cancer Research and Treatment(1)
Clinical Cancer Research(1)
Clinical Chemistry(1)
Human Mutation(1)
Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: A high proportion of mutations unique to Spain and evidence of founder effects
ArticleAbstract: We screened index cases from 410 Spanish breast/ovarian cancer families and 214 patients (19 of themPalabras claves:BRCA1, BRCA2, Breast cancer, hebkp_reditary, Cáncer, SpanishAutores:Alonso C., Armengod M.E., Baiget M., Benitez J., Caldés T., Campos B., Carracedo Á., Cervantes A., Chaves J., Cruz-Hernandez J.J., De la Hoya M., Díaz-Rubio E., Díez O., Durán M., Esteban E., González-Sarmiento R., Martinez-Ferrandis J.I., Miner C., Osorio A., Raquel Salazar-Lugo, Rodríguez-López R., San Román J.M., Torres M., Vega A., Velasco E.Fuentes:scopusGenomic rearrangements at the BRCA1 locus in Spanish families with breast/ovarian cancer
ArticleAbstract: Background: Large genomic rearrangements (LGRs) account for a substantial proportion of the BRCA1 diPalabras claves:Autores:Benitez J., Caldés T., Carracedo Á., De la Hoya M., Díaz-Rubio E., Díez O., Esteban E., González-Sarmiento R., Gutiérrez-Enríquez S., Llort G., Miner C., Osorio A., Raquel Salazar-Lugo, Sánchez-de-Abajo A., Vega A., Velasco E.Fuentes:scopusParity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
ArticleAbstract: Environmental or lifestyle factors are likely to explain part of the heterogeneity in breast and ovaPalabras claves:BRCA1, BRCA2, Breast Cancer, Ovarian Cancer, parityAutores:Baiget M., Balmaña J., Benitez J., Blanco A., Blanco I., Caldés T., Calvo M.T., Chirivella I., De la Hoya M., Díaz-Rubio E., Durán M., Esteban-Cardeñosa E., Guillén-Ponce C., Lasa A., Lázaro C., Martínez De Dueñas E., Milne R.L., Miramar M.D., Osorio A., Ramón Y Cajal T., Raquel Salazar-Lugo, San Román C., Sánchez-Ollé G., Tejada M.I., Teulé A., Urioste M., Vega A., Velasco E.Fuentes:scopusThe average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain
ArticleAbstract: Purpose: It is not clear that the published estimates of the breast and ovarian cancer penetrances oPalabras claves:Autores:Antoniou A.C., Benitez J., Beristain E., Blanco A., Blanco I., Caldés T., Calvo M.T., Carmen Alonso M., Chirivella I., De la Hoya M., Díez O., Durán M., Esteban-Cardeñosa E., Graña B., Guillén-Ponce C., Lázaro C., Llort G., Martínez E., Milne R.L., Miramar M.D., Osorio A., Ramón Y Cajal T., Raquel Salazar-Lugo, Román C.S., Sánchez-de-Abajo A., Tejada M.I., Urioste M., Vega A., Velasco E.Fuentes:scopus